Abstract
Introduction: The year 2019 was affected by Pneumonia caused by SARS Cov 2 virus. This major health challenge whole world is facing and IgG antibodies titre has been widely used to assist the diagnostic and prognostic value. Important aspect of aging is decline in immune function. As per the aging process there are changes at humoral and cellular immune responses leading to impaired immune response which in turn leads to risk of infectivity and decreased vaccine responses. The current study's objectives were to assess the SARS-COV-2 antibody titre in the adult urban Malegaon population and to look for a relationship between age and antibody titre.Methods: Individuals who were residing in densely populated Malegaon village where formerly COVID- 19 was declared as hot spot during first wave were included with total sample size of 2454 and their blood samples were collected to get IgG antibodies from 12 January 2022 to 18 January 2022.Results: In this study we found that when the age advances the % of antibody level doesn’t change significantly. In 2454 samples there observed non-significant difference in antibody % and age group (p>0.05)Conclusion: These findings suggest extensive studies are required to bring uniform guideline for developing the vaccine strategy as age and antibodies level remained the same.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
